TipRanks
GlobeStar Therapeutics (GSTC)
OTHER OTC:GSTC
US Market
GSTC
GlobeStar Therapeutics
RESEARCH TOOLSreports

GlobeStar Therapeutics (GSTC) Income Statement

17 Followers

GlobeStar Therapeutics Income Statement

Last quarter (Q3 2024), GlobeStar Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, GlobeStar Therapeutics's net income was $-198.00K. See GlobeStar Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 77.00$ 425.00
Gross Profit
$ 0.00$ 0.00$ -2.41K$ -37.60K$ 271.00
Operating Expenses
$ 1.86M$ 1.26M$ 9.09M$ 266.07K$ 316.14K
Depreciation and Amortization
$ 1.86M$ 54.66K$ 1.27K$ 1.33K$ 472.00
EBITDA
$ 6.37K$ -1.21M$ -9.09M$ -302.00K$ -314.00K
Operating Income
$ -1.86M$ -1.26M$ -9.09M$ -304.00K$ -316.00K
Other Income/Expenses
$ -84.88K$ -223.00K$ -707.00K$ -238.00K$ -359.00K
Pretax Income
$ -1.95M$ -1.49M$ -9.80M$ -542.00K$ -675.00K
Net Income
$ -1.95M$ -1.49M$ -9.80M$ -542.00K$ -675.00K
Per Share Metrics
Basic EPS
$ >-0.01$ >-0.01$ -0.02$ 0.00$ -0.01
Diluted EPS
$ >-0.01$ >-0.01$ -0.02$ 0.00$ -0.02
Weighted Average Shares Outstanding
 827.32M 628.54M 482.09M 298.09M 104.78M
Weighted Average Shares Outstanding (Diluted)
 827.32M 628.54M 482.09M 298.09M 104.78M
Currency in USD

GlobeStar Therapeutics Earnings and Revenue History